Quick Answer
ACADIA PHARMACEUTICALS INC reported Diluted EPS of $2.30 per share for fiscal year 2025.
ACADIA PHARMACEUTICALS INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $2.30 | +69.1% |
| 2024 | $1.36 | +467.6% |
| 2023 | -$0.37 | +72.4% |
| 2022 | -$1.34 | -27.6% |
| 2021 | -$1.05 | +41.3% |
| 2020 | -$1.79 | -371.1% |
| 2012 | -$0.38 | +13.6% |
| 2011 | -$0.44 | -212.8% |
| 2010 | $0.39 | +132.5% |
| 2009 | -$1.20 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.42 | +110.0% | +162.5% |
| June 30, 2025 | $0.16 | -20.0% | +45.5% |
| March 31, 2025 | $0.11 | +10.0% | -45.0% |
| September 30, 2024 | $0.20 | +150.0% | +0.0% |
| June 30, 2024 | $0.20 | +1900.0% | +100.0% |
| March 31, 2024 | $0.10 | +137.0% | +125.0% |
| September 30, 2023 | -$0.40 | -135.3% | -4100.0% |
| June 30, 2023 | $0.01 | +104.8% | +103.7% |
- ACADIA PHARMACEUTICALS INC showed an increase of +69.1% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2025 period, ACADIA PHARMACEUTICALS INC’s diluted eps has grown by 291.7% (from $1.20 per share (loss) to $2.30 per share).
- The most recent figure is from ACADIA PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: